|
EHBP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.78590533659462E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.79030140607028E-11 |
| Normal-vs-Stage2 |
1.844590E-04 |
| Normal-vs-Stage3 |
3.350700E-04 |
| Normal-vs-Stage4 |
1.62859999996989E-06 |
| Stage1-vs-Stage2 |
7.007400E-01 |
| Stage1-vs-Stage3 |
1.646760E-01 |
| Stage1-vs-Stage4 |
5.633400E-01 |
| Stage2-vs-Stage3 |
4.249000E-01 |
| Stage2-vs-Stage4 |
3.819600E-01 |
| Stage3-vs-Stage4 |
1.114590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.93149948760174E-11 |
| Normal-vs-AfricanAmerican |
1.16260000004864E-06 |
| Normal-vs-Asian |
1.710390E-01 |
| Caucasian-vs-AfricanAmerican |
3.537000E-01 |
| Caucasian-vs-Asian |
5.332000E-01 |
| AfricanAmerican-vs-Asian |
7.714800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.06532577099006E-13 |
| Normal-vs-Female |
2.757900E-02 |
| Male-vs-Female |
1.99273E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.7524999996208E-08 |
| Normal-vs-Extreme_Weight |
2.53896903501527E-12 |
| Normal-vs-Obese |
3.79550000000339E-05 |
| Normal-vs-Extreme_Obese |
8.536300E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.531200E-01 |
| Normal_Weight-vs-Obese |
1.062610E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.453800E-01 |
| Extreme_Weight-vs-Obese |
1.417670E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.326600E-01 |
| Obese-vs-Extreme_Obese |
4.548600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.203160E-01 |
| Normal-vs-Age(41-60Yrs) |
3.21320000051806E-07 |
| Normal-vs-Age(61-80Yrs) |
1.90658600018878E-12 |
| Normal-vs-Age(81-100Yrs) |
3.522899999997E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.279000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.042200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.294400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.056100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.546000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.827800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.23550092168534E-11 |
| Normal-VS-Type2 PRCC |
9.49329503896479E-11 |
| Normal-VS-KIRP CIMP |
1.743360E-01 |
| Normal-VS-Unclassified PRCC |
3.970400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.850800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.968300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.019370E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.712320E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.693800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.380800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.67139968532126E-10 |
| Normal-vs-N1 |
1.095580E-02 |
| Normal-vs-N2 |
5.595500E-03 |
| N0-vs-N1 |
1.828440E-02 |
| N0-vs-N2 |
7.569600E-01 |
| N1-vs-N2 |
4.628400E-01 |
|
|
